Answers are grounded in this paper and cite their sources.
Background: Lon Peptidase 1 (LONP1) is a mitochondrial protease responsible for maintaining mitochondrial proteostasis and cellular adaptation to stress. Overexpression of LONP1 has been implicated in cancer progression across multiple malignancies. Given the critical role of LONP1 in cancer cell survival, we sought to determine whether its pharmacological inhibition could impair cancer cell adaptation to endoplasmic reticulum (ER) stress and promote immunogenicity-associated features. Methods: We used the B16-F10 murine melanoma cell line as an in vitro model to study the effects of Methyl-2-cyano-3,12-dioxooleana-1,9-diene-28-oate (CDDO-Me), a pharmacological inhibitor of LONP1. ER stress was induced using Thapsigargin and Tunicamycin. Western blotting was employed to assess expression levels of target proteins. Flow cytometry was performed to evaluate surface markers, as well as intracellular probes. TIMER 2.0 and TNMplot databases were used to explore the clinical relevance of LONP1 expression in patients with cutaneous melanoma. Results: Our data demonstrate that ER stress upregulates LONP1 expression in B16-F10 melanoma cells. Pharmacological inhibition of LONP1 with CDDO-Me during ER stress leads to a significant accumulation of melanoma cells in the sub G1 phase associated with high surface exposure of calreticulin, MHC class I, and extracellular ATP release. In addition, treatment with CDDO-Me in the presence of ER stress impairs autophagic activity as evidenced by elevated LC3-II levels, and p62 accumulation. TNMplot shows an upregulation of LONP1 expression in malignant tissues compared to their normal counterparts across various cancer types. TIMER 2.0 reveals a negative correlation between LONP1 expression and markers of antitumor immunity. Conclusions: Collectively, these results provide mechanistic insights into the antitumor activity of CDDO-Me in stressed melanoma cells and support the therapeutic potential of targeting LONP1 in melanoma.
No takes yet. Share an insight, caveat, or question.
Darling et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: